GenTeal Tears (Moderate) Dextran 70, Glycerin, Hypromellose 70 1 mg/mL; 2 mg/mL; 3 mg/mL Solution/ Drops — NDC 00065-0426-36 package photo
Label image from the product's FDA listing (DailyMed) — may show a different pack size or an older label revision.

GenTeal Tears (Moderate) Dextran 70, Glycerin, Hypromellose 70 1 mg/mL; 2 mg/mL; 3 mg/mL Solution/ Drops — NDC 0065-0426-36 (Billing 00065-0426-36)

by Alcon Laboratories, Inc. · 1 BOTTLE, DROPPER in 1 CARTON / 15 mL in 1 BOTTLE, DROPPER

This is a package of GenTeal Tears (Moderate) Dextran 70, Glycerin, Hypromellose 70 1 mg/mL; 2 mg/mL; 3 mg/mL Solution/ Drops from Alcon Laboratories, Inc., marketed since Mar 2016 and currently FDA-listed; retail pharmacies pay about $0.4807 per mL (NADAC). It is the main listing for this product, which comes in 2 package sizes.

NDC 00065-0426-36
🏷️ FDA NDC (as labeled) 0065-0426-36 billing pads the labeler segment with a zero
This package
Contains15 mL in 1 bottle, dropper Cost per mL$0.4807 NADAC Per package$7.21 / 15 ml Pack sizes2 compare ↓
Also priced by: Medicaid pays $1.45/unit — full pricing hub ↓
Main listing for product 0065-0426 · Also comes in: 2 bottles 0065-0426-37
OTC On market Non-controlled ⇄ Compare with another NDC
🗂️ FDA directory synced Oct 1, 2026 · this listing last changed Oct 1, 2026 · sources: openFDA · FDA label (DailyMed) · FDA Orange & Purple Book · First Databank · CMS NADAC, ASP, Medicare & Medicaid · RxNorm
📋 All sources & update times →

NDC database record

One package, one record: these facts belong to NDC 0065-0426-36 alone.

Record
FDA NDC Directory package listing · Human OTC drug
Code segments
0065 labeler · 0426 product · 36 package
Package marketed since
Mar 1, 2016
Sample package
No — commercial package
Listing certified through
Dec 31, 2026
Barcode (UPC-A, from the NDC)
3 0065042636 7
Medicaid fills, this package
22,979 prescriptions in the last four reported quarters
FDA record last changed
Oct 1, 2026

Identity & classification

Regulatory identifiers FDA, NLM and CMS codes for this package

FDA NDC (as labeled) 0065-0426-36
Product NDC 0065-0426
11-digit billing NDC 00065042636
NCPDP billing unit ML — per mL (volume)
RxCUI 900138
UNII 7SA290YK68, PDC6A3C0OX, 3NXW29V3WO
Application # M018
SPL Set ID a2992597-3490-6a5c-be45-2b6fa15e1547
Established class (EPC) Plasma Volume Expander; Non-Standardized Chemical Allergen
Mechanism of action Osmotic Activity
Physiologic effect Increased Intravascular Volume; Increased Histamine Release; Cell-mediated Immunity; Increased IgG Production
Chemical class Allergens; Glycerol
DEA schedule Non-controlled
Marketing category OTC MONOGRAPH DRUG
Marketing status On market
FDA listing status Listed (active directory)
Marketing start 2016-03-01
Route OPHTHALMIC
Dosage form SOLUTION/ DROPS
Substance DEXTRAN 70; GLYCERIN; HYPROMELLOSES

Drug-database identifiers Medi-Span GPI and First Databank GCN / HICL / AHFS classification

GPI-14 86201000002000
GPI class GenTeal Tears
GCN Seq No 047660
GCN 13064
HICL code 022019
Ingredient (HICL) Dextran/Hypromellose/Glycerin
HIC1 code Q
Therapeutic class — broad (HIC1) Ear/Eye/Nose/Rectum/Topical/Vagina/Other
HIC2 code Q6
Therapeutic class — intermediate (HIC2) Ophthalmic Preparations
HIC3 code Q6T
Therapeutic class — specific (HIC3) Artificial Tears
AHFS code 52:92.00.00
AHFS class Eent Drugs, Miscellaneous
FDB label name GENTEAL TEARS 0.1%-0.2%-0.3%
FDB brand name Genteal Tears
Legend status O — Over-the-counter (OTC) drug or device
Quick answers
  • GSN (GCN sequence number): 047660
  • GCN: 13064
  • GPI-14 (Medi-Span): 86201000002000
  • HICL (First Databank): 022019
  • AHFS class code: 52:92.00.00
  • RxCUI (RxNorm): 900138
Why two NDCs? The FDA registers this code as 0065-0426-36 — a 4-4-2 layout, and that's what's printed on the package and shown on DailyMed. For insurance claims, every NDC is standardized to a uniform 11-digit 5-4-2 format by adding a zero to the labeler segment → 00065-0426-36. Same drug, same package — only the format differs.
Where does this data come from?
Identifiers from the FDA openFDA NDC Directory and Structured Product Labeling; RxCUI from RxNorm (NLM); GPI from Medi-Span; GCN / HIC / AHFS / legend from First Databank.

RxNorm drug class

This medicine belongs to the Viscoelastic substances class.

Drug family (ATC) Viscoelastic substances
Where does this data come from?
Therapeutic classes from RxNorm RxClass (U.S. National Library of Medicine) — Established Pharmacologic Class (FDA), ATC drug family (WHO) and mechanism of action, matched by this product’s RxCUI.

Clinical

Label name GENTEAL TEARS 0.1%-0.2%-0.3% Ingredient Dextran/Hypromellose/Glycerin
🧪 What is this product?

GenTeal Tears (Moderate) is an over-the-counter eye drop solution containing dextran 70, glycerin, and hypromellose. These ingredients are commonly combined in artificial tear products to help lubricate and moisturize the eye surface. Dextran and hypromellose function as thickening agents that help the drops coat the eye, while glycerin adds moisture-retaining properties. This product is an OTC monograph drug, meaning it is marketed under established FDA guidelines for the artificial tears category.

Where does this data come from?
Plain-language summary from MedlinePlus (U.S. National Library of Medicine); supplement & herbal interactions and nutrient depletion data from the Natural Medicines database; our full guide is HelloPharmacist editorial content.

Pricing

A drug doesn't have one price. Each row is a different public payment system, and none is what you'd pay at the counter — that depends on your insurance. The ⓘ on each row explains what it measures.

Price systemPer mLPer package
Retail pharmacies payNADAC · weekly $0.481 $7.21 / 15 ml
Medicaid paysCMS SDUD · 12 mo $1.45 $21.76 / 15 ml
Medicare drug plans payPart D · quarterly No Part D plan price is available for this NDC in our data.
NADAC price history (per mL) — tap or hover for the price & month
Sep 2021 Dec 2023 Mar 2026 Sep 2026 $0.503 $0.418
▲ Up 11% over the last 18 months.
Where does this data come from?
NADAC (National Average Drug Acquisition Cost) is the CMS weekly pharmacy-acquisition-cost survey — what pharmacies pay. ASP (Average Sales Price) is the CMS Medicare Part B drug-payment file, published quarterly. Medicaid pays is computed by us from CMS State Drug Utilization Data (total reimbursed ÷ units, trailing 12 months) — gross of rebates and inclusive of dispensing fees, so it reflects what Medicaid paid, not an acquisition cost. Medicare drug plans pay is the median negotiated point-of-sale unit cost across plans listing this NDC in the CMS quarterly Prescription Drug Plan pricing files, before rebates. The VA pays is the federal contract price (FSS, and the statutory Big 4 ceiling where listed) from the VA National Acquisition Center pharmaceutical price file. All are free public government data; each measures a different payer, so the figures are not directly comparable.

Packaging — all sizes for this product

Package NDCDescription Per unit Per pack Marketing startMarketing endStatus
00065-0426-36 You're viewing this Main listing 1 BOTTLE, DROPPER in 1 CARTON / 15 mL in 1 BOTTLE, DROPPER $0.4807 / mL $7.21 2016-03-01 — Active
00065-0426-37 0065-0426-37 2 BOTTLE, DROPPER in 1 CARTON / 15 mL in 1 BOTTLE, DROPPER $0.4250 / mL $12.75 2016-03-01 — Active

Per mL, this pack runs about 13% above the cheapest pack (NDC 00065-0426-37, $0.4250 vs $0.4807 NADAC).

In Medicaid, this is the most-dispensed pack of this product — about 99% of fills over the last four reported quarters. See all packs ↓

Pack size FAQ

What quantity is in this package?
This package is listed by the FDA — 1 bottle, dropper in 1 carton / 15 ml in 1 bottle, dropper.
What NDC number is used to bill for this package of GenTeal Tears (Moderate) Dextran 70, Glycerin, Hypromellose 70 1 mg/mL; 2 mg/mL; 3 mg/mL Solution/ Drops?
Use the 11-digit billing form listed in the identifiers section of this page. Pharmacy and medical claims use the 11-digit form; the FDA label may print a shorter form of the same code.

Prices are the latest CMS NADAC pharmacy acquisition cost per NDC; per-pack figures are per-unit × pack quantity, shown only when the pack is denominated in the same measure NADAC prices.

Therapeutic equivalents

ProductLabelerPackNADAC/unitTEStatusPrice vs. this
Artificial Tears 70 1 mg/mL; 2 mg/mL; 3 mg/mL 50268-0043-15 AvPAK 15 ml $0.404 — Availability likely save 16%
GenTeal Tears (Moderate) 70 1 mg/mL; 2 mg/mL; 3 mg/mLthis 00065-0426-36 Alcon 1 bottle $0.481 — Availability likely —
Genteal Tears 70 1 mg/mL; 2 mg/mL; 3 mg/mL 50090-5050-00 A-S 1 bottle — — FDA listed —
About this product: other versions of the same ingredient, strength and form are listed above, least expensive first, with FDA equivalence ratings where available.
Where does this data come from?
Equivalents are other NDCs of the same ingredient, form and route from the openFDA NDC Directory, ranked least-expensive-first by NADAC. Therapeutic-equivalence (AB) ratings come from the FDA Orange Book; biologics use the FDA Purple Book for biosimilar & interchangeable status.

Availability & generic status

🏛️
2016
On the market since
Mar 2016
📍
2026
Currently FDA-listed
10 years listed
🔒
·
No generic listed yet
brand only
ℹ️No FDA-approved generic found

We did not find an FDA-approved generic match for this exact strength, form and route.

Where does this data come from?
Patents and exclusivity from the FDA Orange Book (small-molecule drugs), refreshed from public FDA data. Generic launch timing is an estimate, not a guarantee.

Inactive Ingredients / Excipients

Inactive ingredients, also called excipients, are components of the drug product other than the active ingredient. They may include fillers, dyes, coatings, preservatives, flavors, or other formulation ingredients.

💡 Tap an ingredient (hover on desktop) to see what it is and why it’s used.

  • UNII R57ZHV85D4
    Boric acid is a weak acid derived from boron. In medicines, it typically serves as a buffer to help maintain the product's pH level and may act as a preservative in certain formulations.
  • UNII M4I0D6VV5M
    Calcium chloride is a salt compound that acts as a firming agent and source of calcium ions in medications. It's used in formulations to help maintain tablet structure, improve texture, or serve as a buffering agent.
  • UNII TE7660XO1C
    Glycine is an amino acid used in medicines as a buffer to help stabilize pH and improve taste. It may also serve as a filler or binder to give the product proper form and consistency.
  • UNII QTT17582CB
    A strong acid used to adjust and maintain the proper pH level in liquid medicines, ensuring stability and preventing breakdown of active ingredients.
  • UNII 02F3473H9O
    A mineral salt used in medications as a source of magnesium. It helps bind ingredients together, improve texture, and maintain the product's stability during storage.
  • UNII 6716Z5YR3G
    A synthetic polymer compound used as an antimicrobial preservative and stabilizer in pharmaceutical formulations. It helps prevent microbial growth and maintain product stability during storage.
  • UNII 6OZP39ZG8H
    Polysorbate 80 is a synthetic emulsifier derived from sorbitol and oleic acid. It helps mix oil and water-based ingredients together in medications and improves how the product disperses in the body.
  • UNII 660YQ98I10
    Potassium chloride is a mineral salt used in medicines as a buffer and to help maintain the proper pH balance and stability of the formulation during storage and use.
  • UNII 451W47IQ8X
    Sodium chloride is common table salt. It's used in medicines as a buffer to maintain proper pH, as a filler to add bulk, or to adjust the osmotic balance in liquid formulations.
  • UNII 55X04QC32I
    A strong alkaline chemical used to adjust and maintain the pH balance of liquid medicines. It helps keep the medicine stable and ensures it stays effective during storage.
  • UNII 059QF0KO0R
    Water is a liquid solvent that dissolves and mixes ingredients together in liquid medicines, syrups, and injections. It helps distribute the active drug evenly throughout the product.
  • UNII 86Q357L16B
    Zinc chloride is a mineral salt used as a buffer and pH regulator in medications. It helps maintain the chemical stability and proper acidity level of the drug formulation.

12 inactive ingredients listed in the exact product block matched to this NDC.

The official label also statesboric acid, calcium chloride, glycine, hydrochloric acid and/or sodium hydroxide (to adjust pH), magnesium chloride, POLYQUAD * (polyquaternium-1) 0.001% preservative, polysorbate 80, potassium chloride, purified water, sodium chloride, zinc chloride.

Label-section wording can be broader than the structured product block and may mention additional formulation ingredients.

Where does this data come from?
Data sourced from official FDA Structured Product Labeling (SPL) via DailyMed — ingredient classCode="IACT" elements from the exact product block matched by this NDC. Label-section narrative from DailyMed / the openFDA label index is shown separately when available.

Inactive ingredient FAQ

Are inactive ingredients the same for every manufacturer?
No. Inactive ingredients can differ by manufacturer, dosage form, strength, and package / product version.
Why might an inactive ingredient be missing?
Some SPLs do not provide a complete structured inactive-ingredient list, and older or unusual labels may only include the information in narrative text.
Can inactive ingredients matter?
Yes. They can matter for allergies, intolerances, dyes, gluten / lactose concerns, preservatives, and formulation differences — but confirm with a pharmacist or the manufacturer when it’s clinically important.

Manufacturer & labeler

LabelerAlcon Laboratories, Inc.
FDA applicationM018 (OTC MONOGRAPH DRUG)
Labeler code00065
First marketedMar 2016
Product typeHuman Otc Drug
Portfolio55 products on file
The labeler markets the product; the application holder owns the FDA approval. They’re often the same company but can differ (e.g. a repackager or an authorized generic). A mailing address / phone appears here when the manufacturer includes it in the product’s FDA label (not all do).
Where does this data come from?
Labeler, application holder and registered establishment from the FDA openFDA NDC Directory and Drugs@FDA; address/contact from the product’s FDA label.

FDA label — Drug Facts FDA SPL

The complete FDA label for this product — the official Drug Facts labeling, verbatim, section by section. Jump with a chip, search within the label, or expand everything.
🎯 Indications and Usage 37 words ▾

Uses temporary relief of burning and irritation due to dryness of the eye as a protectant against further irritation temporary relief of discomfort due to minor irritations of the eye or to exposure to wind or sun

⏱️ Dosage and Administration 12 words ▾

Directions put 1 or 2 drops in the affected eye(s) as needed

⚠️ Warnings 5 words ▾

Warnings For external use only

📦 Storage and Handling 6 words ▾

Other Information store at room temperature

🧪 Active Ingredient 13 words ▾

Active ingredients Purpose Dextran 70 0.1% Lubricant Glycerin 0.2% Lubricant Hypromellose 0.3% Lubricant

🧪 Inactive Ingredients 32 words ▾

Inactive ingredients: boric acid, calcium chloride, glycine, hydrochloric acid and/or sodium hydroxide (to adjust pH), magnesium chloride, POLYQUAD * (polyquaternium-1) 0.001% preservative, polysorbate 80, potassium chloride, purified water, sodium chloride, zinc chloride.

🎯 Purpose 13 words ▾

Active ingredients Purpose Dextran 70 0.1% Lubricant Glycerin 0.2% Lubricant Hypromellose 0.3% Lubricant

📄 Do Not Use 21 words ▾

Do not use if this solution changes color or becomes cloudy if you are sensitive to any ingredient in this product

📄 When Using This Product 21 words ▾

When using this product do not touch tip of container to any surface to avoid contamination replace cap after each use

📄 Stop Use and Ask a Doctor If 36 words ▾

Stop use and ask a doctor if you experience any of the following: you feel eye pain changes in vision continued redness or irritation of the eye condition worsens or persists for more than 72 hours

📄 Keep Out of Reach of Children 19 words ▾

Keep out of reach of children. If swallowed, get medical help or contact a Poison Control Center right away.

📄 Questions or Comments 10 words ▾

Questions? In the U.S. call 1-800-757-9195 (Mon-Fri 9AM-5PM CST) [email protected]

📄 Package Label / Principal Display Panel ~2 min read ▾

PRINCIPAL DISPLAY PANEL NDC 0065-0426-36 Moderate DRY EYE SYMPTOM RELIEF GenTeal ® Tears LUBRICANT EYE DROPS LIQUID DROPS Fast Soothing Relief PREVIOUSLY TEARS NATURALE ® FORTE STERILE 15 mL (0.5 FL OZ) Alcon TAMPER EVIDENT: For your protection, this bottle has an imprinted seal around the neck. Do not use if seal is damaged or missing at time of purchase. Distributed by: ALCON LABORATORIES, INC.

Fort Worth, Texas 76134 USA Country of Origin: USA 300048636-0621 NDC 0065-0426-37 TWIN PACK Moderate DRY EYE SYMPTOM RELIEF GenTeal ® Tears LUBRICANT EYE DROPS LIQUID DROPS Fast Soothing Relief STERILE Two 15 mL (0.5 FL OZ) bottles each Alcon TAMPER EVIDENT: For your protection, this bottle has an imprinted seal around the neck. Do not use if seal is damaged or missing at time of purchase. Distributed by: ALCON LABORATORIES, INC.

Fort Worth, Texas 76134 USA Country of Origin: USA ©2017 Alcon Inc. 9017786-0819 NDC 0065-0426-36 Moderate DRY EYE SYMPTOM RELIEF GenTeal ® Tears LUBRICANT EYE DROPS LIQUID DROPS Fast Soothing Relief STERILE 15 ml (0.5 FL OZ) STERILE-FOR TOPICAL EYE USE ONLY Uses: For the temporary relief of burning and irritation due to dryness of the eye and for use as a protectant against further irritation. For the temporary relief of discomfort due to minor irritation of the eye or to exposure to wind or sun.

Directions: put 1 or 2 drops in the affected eye(s) as needed. Warnings: If solution changes color or becomes cloudy, do not use. To avoid contamination, do not touch tip of container to any surface.

Replace cap after using. Keep this and all drugs out of the reach of children. See carton for complete Warnings.

INGREDIENTS: Each mL contains: Active: Dextran 70 0.1%, Glycerin 0.2% and Hypromellose 0.3%. Preservative: POLYQUAD* (polyquaternium-1) 0.001%. Inactives: boric acid, calcium chloride, glycine, hydrochloric acid and/or sodium hydroxide (to adjust pH), magnesium chloride, polysorbate 80, potassium chloride, purified water, sodium chloride, zinc chloride.

TAMPER EVIDENT: For your protection, this bottle has an imprinted seal around the neck. Do not use if seal is damaged or missing at time or purchase. Store at room temperature.

Alcon Distributed by: ALCON LABORATORIES, INC. Fort Worth, Texas 76134 USA LOT: EXP: 300048635-0621

Source: FDA Structured Product Labeling, mirrored from DailyMed / openFDA. Prefer the government’s original formatting? View this label on DailyMed ↗

Medicaid utilization & spend

📍 This exact package only: Medicaid data is reported per full 11-digit NDC — labeler, product and pack size — so every number here is for this package alone, not the drug overall. Other pack sizes report separately.
💊 Pharmacy benefit only: These are Medicaid outpatient pharmacy claims, billed by NDC. They exclude the medical benefit — clinic- or hospital-administered drugs billed under HCPCS J-codes — so drugs used mostly that way (e.g. Avastin, Lucentis, Keytruda) can look low or missing here. That’s expected, not an error.
📅 Q1 2025 – Q1 2026 · 5 quarters of data
ⓘ The newest quarter is usually incomplete when first published; states restate recent quarters in later CMS releases, so the latest figures typically revise upward. State coverage-policy changes can also shift quarter-to-quarter totals.
Prescriptions last 4 qtrs
23K
Units reimbursed last 4 qtrs
351.8K
Gross reimbursed last 4 qtrs
$510.4K
Avg / prescription
$22.21
Avg / unit
$1.4507
Latest quarter Q1 2026
5.4KRx
Medicaid pays / mL
$1.4507
gross reimbursed
vs
NADAC / mL
$0.4807
acquisition cost
=
Spread
+$0.9700
+202% vs cost
What Medicaid paid per mL (before rebates; includes the pharmacy’s dispensing fee) compared with NADAC — the average price pharmacies pay to buy the drug. A positive spread means Medicaid reimbursed more than the purchase price, before manufacturer rebates.
Fee-for-service vs managed care ⓘ
48% FFS 52% MCO
Fee-for-service · 10,945 Rx Managed care · 12,034 Rx
State Medicaid map
Alaska: no data reported AK Maine: 5,215 units · 374 per 100k residents ME Washington: no data reported WA Idaho: no data reported ID Montana: no data reported MT North Dakota: no data reported ND Minnesota: 34,377 units · 599 per 100k residents MN Wisconsin: no data reported WI Michigan: 7,335 units · 73.1 per 100k residents MI New York: 165 units · 0.8 per 100k residents NY Vermont: 3,435 units · 531 per 100k residents VT New Hampshire: 360 units · 25.7 per 100k residents NH Oregon: 1,500 units · 35.4 per 100k residents OR Nevada: 4,515 units · 141 per 100k residents NV Wyoming: no data reported WY South Dakota: no data reported SD Iowa: 4,230 units · 132 per 100k residents IA Illinois: 104,113 units · 830 per 100k residents IL Indiana: 15,376 units · 224 per 100k residents IN Ohio: 46,681 units · 396 per 100k residents OH Pennsylvania: 28,697 units · 221 per 100k residents PA New Jersey: 15,615 units · 168 per 100k residents NJ Massachusetts: no data reported MA California: 14,163 units · 36.3 per 100k residents CA Utah: no data reported UT Colorado: no data reported CO Nebraska: 6,109 units · 309 per 100k residents NE Missouri: no data reported MO Kentucky: 28,962 units · 640 per 100k residents KY West Virginia: no data reported WV Virginia: 4,272 units · 49.0 per 100k residents VA Maryland: 850 units · 13.8 per 100k residents MD Connecticut: no data reported CT Rhode Island: 3,990 units · 364 per 100k residents RI Arizona: 3,474 units · 46.8 per 100k residents AZ New Mexico: 9,616 units · 455 per 100k residents NM Kansas: no data reported KS Arkansas: no data reported AR Tennessee: no data reported TN North Carolina: no data reported NC South Carolina: 1,395 units · 26.0 per 100k residents SC Delaware: 1,410 units · 137 per 100k residents DE Oklahoma: no data reported OK Louisiana: no data reported LA Mississippi: no data reported MS Alabama: no data reported AL Georgia: no data reported GA D.C.: 1,305 units · 192 per 100k residents DC Hawaii: 4,680 units · 326 per 100k residents HI Texas: no data reported TX Florida: no data reported FL
Units reimbursed · per 100k residents
0.8830
gray = no data reported ⓘ
Colors are per 100,000 residents, so big states don’t automatically dominate. Tap or hover a state for its actual totals.
Tap or hover a state
…for its Medicaid breakdown
🏆 Top states by units · per 100k residents
1 Illinois 830 /100k
2 Kentucky 640 /100k
3 Minnesota 599 /100k
4 Vermont 531 /100k
5 New Mexico 455 /100k
6 Ohio 396 /100k
7 Maine 374 /100k
8 Rhode Island 364 /100k
National units — by quarter
💵 About the dollar figures: “reimbursed” is what Medicaid paid pharmacies before confidential manufacturer rebates, so the program’s real net cost is lower than these numbers. Fee-for-service and managed-care claims are combined unless split above. Source: CMS State Drug Utilization Data; per-100k rates use 2023 Census population estimates.

Medicaid utilization by pack size

Medicaid (SDUD) totals over the four most recent reported quarters for every package size of this drug — handy when a specific package (e.g. a starter/titration pack) carries little or no Medicaid volume on its own.
1 bottle this page00065-0426-36 22,979 Rx · $510,410
2 bottles00065-0426-37 289 Rx · $5,381
Drug total (last 4 qtrs): 23,268 Rx · 359,389 units · $515,791 gross reimbursed
Tap a pack size to open its page. Source: CMS State Drug Utilization Data, last 4 quarters.

Reported adverse events (FAERS)

Read carefully: FAERS reports are voluntary and unverified. Counts are not incidence, do not establish causation, are subject to reporting bias, and cannot be used to compare one drug to another. Shown for signal context only. Reports for Dextran 70, Glycerin, Hypromellose — the ingredient across all brands.

Top reported reactions

Eye Irritation1
Instillation Site Pain1

Reporter sex

0 reports
Where does this data come from?
Adverse-event reports from the FDA Adverse Event Reporting System (FAERS) via openFDA. FAERS reports are voluntary and unverified — counts are not incidence and don’t establish causation.
For educational and professional reference only — not medical advice. Pricing reflects published NADAC and CMS ASP (free public data) and may differ from your acquisition cost; always verify before billing or dispensing.